Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab-Reference-Cited by-同舟云学术

Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab

Published:2016-03-28 Issue:9 Volume:10 Page:1015-1023
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Papamichael Konstantinos,Rivals-Lerebours Oliviane,Billiet Thomas,Vande Casteele Niels,Gils Ann,Ferrante Marc,Van Assche Gert,Rutgeerts Paul J.,Mantzaris Gerassimos J.,Peyrin-Biroulet Laurent,Vermeire Severine

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/10/9/1015/13746650/jjw067.pdf

Reference42 articles.

1. Targeting TNF-α for the treatment of inflammatory bowel disease

2. Tailoring anti-TNF therapy in IBD: drug levels and disease activity

3. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

4. Optimizing anti-TNF treatments in inflammatory bowel disease

5. Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colon‐adhesive poly(maleic anhydride)‐sirolimus conjugate alleviates local colitis inflammation;Journal of Applied Polymer Science;2024-09-04

2. Clinical Utility of Disease Activity Indices in Predicting Short-Term Response to Biologics in Patients with Ulcerative Colitis;Journal of Clinical Medicine;2024-06-13

3. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

4. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05

5. Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials;JGH Open;2024-04